Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery
- 1 December 2017
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (3) , 612-616
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United StatesGynecologic Oncology, 2016
- Unique Human Papillomavirus-Type Distribution in South African Women With Invasive Cervical Cancer and the Effect of Human Immunodeficiency Virus InfectionInternational Journal of Gynecological Cancer, 2015
- Predictors of Intensive Care Unit Utilization in Gynecologic Oncology SurgeryInternational Journal of Gynecological Cancer, 2011
- Predictors of extended intensive care unit resource utilization following surgery for ovarian cancerGynecologic Oncology, 2007
- Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease☆Gynecologic Oncology, 2007
- Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: a university teaching hospital experienceInternational Journal of Gynecological Cancer, 2006
- Resources and use of the intensive care unit in patients who undergo surgery for ovarian carcinomaCancer, 2002
- Surgical intensive care unit care after ovarian cancer surgery: An analysis of indicationsAmerican Journal of Obstetrics and Gynecology, 1997